[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Biotech Beast @Biotech_Beast on x 1718 followers
Created: 2025-07-24 15:28:10 UTC
$ALT has recovered slightly the past month since data from the IMPACT trial of pemvidutide in MASH produce mixed results at XX weeks. The fibrosis improvement isn't on par with $ETNB and $AKRO, although pemvidutide has other advantages.
XXX engagements
Related Topics akro alt $akro $etnb $alt alt aptoslaunch token coins dao